source
- Promising pancreatic cancer drug daraxonrasib shows near-double survival, patients await expanded accessAmy Johnston, diagnosed with pancreatic cancer last year, has undergone chemotherapy and surgery and is now in a clinical trial that hopes to delay disease progression. She expects results by the e…
- Lilly and Boehringer cut German investments amid health-spending overhaulA proposed overhaul of Germany's health-insurance financing is sparking criticism from industry groups. Eli Lilly and Boehringer Ingelheim announced they will reduce their investment programmes in…